Summary
This prediction ended on 14.12.24 with a price of €180.35. The prediction had a final performance of 12.05%. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| UCB S.A. | -7.671% | -7.671% | 58.286% |
| iShares Core DAX® | -1,74 % | 5,67 % | 7,84 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % | 36,61 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % | 45,65 % |
| iShares S&P 500 | 0,97 % | 7,24 % | 26,97 % |
According to BiotechBee what are the pros and cons of UCB S.A. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread UCB S.A. diskutieren
Buy mit Kursziel 210,0